Quitline

Last updated

Quitlines are telephone helplines offering treatment for addiction and behavior change/issues. Presently most quitlines treat tobacco or alcohol addiction. Quitlines are treatment centres that offer advanced treatment and should not be confused with call centres.

Contents

Smoking cessation quitlines

Tobacco quitlines have proven to be comparable to cessation clinics in terms of proportion of smokers smoke-free at follow-up [1] [2] [3] [4] but are more cost effective. [5] A 2008 meta-analysis by the Agency for Healthcare Research and Quality, an agency of the U.S. Department of Health & Human Services, found that quitline counseling increased the estimated long-run (>6 months) abstinence rate to 12.7% compared to 8.5% of smokers attempting to quit on their own; when combined with medication, the estimated long-run abstinence rate increased to 28.1% compared to 23.2% for just medication alone, a "robust effect". [6]

The treatment protocol in most tobacco cessation quitlines is a mixture of motivational interviewing, [7] behaviour therapy, and pharmacological consultation. Quitline numbers are printed on cigarette packages in several countries as a part of the health warning labels. Tobacco quitlines may offer a reactive service, meaning that counselors initiate no contact but clients signing up for support are encouraged to call the service whenever they need, or a proactive service where clients signing up for treatment are offered a call up service. [8] Many quitlines offer both reactive and proactive treatments and leave it up to the client to choose.

Alcohol quitlines

Telephone based advice (call centres) for alcoholics and their relatives are relatively common and some are gradually developing into telephone based treatment centres. However, alcohol quitlines are still in their infancy. In Sweden where telephone-based treatment for tobacco addiction is well established, an advanced alcohol treatment quitline (first of its kind) opened in January 2007. [9] The service is run in close collaboration with the Swedish national tobacco quitline. The primary aim of the Swedish alcohol quitline is to support people who are starting to lose control over their alcohol consumption to regain control. The treatment protocol is based on motivational interviewing and cognitive behavioral therapy offering support to excessive consumers of alcohol and relatives alike.

See also

Related Research Articles

<span class="mw-page-title-main">Tobacco smoking</span> Practice of burning tobacco and breathing the resulting smoke

Tobacco smoking is the practice of burning tobacco and ingesting the resulting smoke. The smoke may be inhaled, as is done with cigarettes, or simply released from the mouth, as is generally done with pipes and cigars. The practice is believed to have begun as early as 5000–3000 BC in Mesoamerica and South America. Tobacco was introduced to Eurasia in the late 17th century by European colonists, where it followed common trade routes. The practice encountered criticism from its first import into the Western world onwards but embedded itself in certain strata of a number of societies before becoming widespread upon the introduction of automated cigarette-rolling apparatus.

<span class="mw-page-title-main">Smoking cessation</span> Process of discontinuing tobacco smoking

Smoking cessation, usually called quitting smoking or stopping smoking, is the process of discontinuing tobacco smoking. Tobacco smoke contains nicotine, which is addictive and can cause dependence. As a result, nicotine withdrawal often makes the process of quitting difficult.

<span class="mw-page-title-main">Drug rehabilitation</span> Processes of treatment for drug dependency

Drug rehabilitation is the process of medical or psychotherapeutic treatment for dependency on psychoactive substances such as alcohol, prescription drugs, and street drugs such as cannabis, cocaine, heroin or amphetamines. The general intent is to enable the patient to confront substance dependence, if present, and stop substance misuse to avoid the psychological, legal, financial, social, and physical consequences that can be caused.Citation needed

Aversion therapy is a form of psychological treatment in which the patient is exposed to a stimulus while simultaneously being subjected to some form of discomfort. This conditioning is intended to cause the patient to associate the stimulus with unpleasant sensations with the intention of quelling the targeted behavior.

<span class="mw-page-title-main">Nicotine replacement therapy</span> Treatment for tobacco use disorder

Nicotine replacement therapy (NRT) is a medically approved way to treat people with tobacco use disorder by taking nicotine through means other than tobacco. It is used to help with quitting smoking or stopping chewing tobacco. It increases the chance of quitting tobacco smoking by about 55%. Often it is used along with other behavioral techniques. NRT has also been used to treat ulcerative colitis. Types of NRT include the adhesive patch, chewing gum, lozenges, nose spray, and inhaler. The use of multiple types of NRT at a time may increase effectiveness.

<span class="mw-page-title-main">Chain smoking</span> Practice of smoking several cigarettes/cigars in succession

Chain smoking is the practice of smoking several cigarettes in succession, sometimes using the ember of a finishing cigarette to light the next. The term chain smoker often also refers to a person who smokes relatively constantly, though not necessarily chaining each cigarette. The term applies primarily to cigarettes, although it can be used to describe incessant cigar and pipe smoking as well as vaping. It is a common indicator of addiction.

Ásgeir R. Helgason is an Icelandic scientist working at Karolinska Institutet in Sweden. Since 2002 he has been an associate professor in psychology at the Departments of Oncology-Pathology and Public Health at the Karolinska Institutet and Reykjavik University, Iceland.

Dr. Shu-Hong Zhu is a Chinese scientist living in the United States. He is best known for his pioneering research on the effectiveness of telephone based treatment for tobacco cessation (quitline).

NicVAX is an experimental conjugate vaccine intended to reduce or eliminate physical dependence to nicotine. According to the U.S. National Institute of Drug Abuse, NicVAX can potentially be used to inoculate against nicotine addiction. This proprietary vaccine is being developed by Nabi Biopharmaceuticals of Rockville, MD. with the support from the U.S. National Institute on Drug Abuse. NicVAX consists of the hapten 3'-aminomethylnicotine which has been conjugated (attached) to Pseudomonas aeruginosa exotoxin A.

<span class="mw-page-title-main">Nicotine withdrawal</span> Process of withdrawing from nicotine addiction

Nicotine withdrawal is a group of symptoms that occur in the first few weeks after stopping or decreasing use of nicotine. Symptoms include intense cravings for nicotine, anger or irritability, anxiety, depression, impatience, trouble sleeping, restlessness, hunger or weight gain, and difficulty concentrating. Withdrawal symptoms make it harder to quit nicotine products, and most methods for quitting smoking involve reducing nicotine withdrawal. Quit smoking programs can make it easier to quit. Nicotine withdrawal is recognized in both the American Psychiatric Association Diagnostic and Statistical Manual and the WHO International Classification of Diseases.

Tobacco harm reduction (THR) is a public health strategy to lower the health risks to individuals and wider society associated with using tobacco products. It is an example of the concept of harm reduction, a strategy for dealing with the use of drugs. Tobacco smoking is widely acknowledged as a leading cause of illness and death, and reducing smoking is vital to public health.

<span class="mw-page-title-main">Nicotine dependence</span> Chronic disease

Nicotine dependence is a state of dependence upon nicotine. Nicotine dependence is a chronic, relapsing disease defined as a compulsive craving to use the drug, despite social consequences, loss of control over drug intake, and emergence of withdrawal symptoms. Tolerance is another component of drug dependence. Nicotine dependence develops over time as a person continues to use nicotine. The most commonly used tobacco product is cigarettes, but all forms of tobacco use and e-cigarette use can cause dependence. Nicotine dependence is a serious public health problem because it leads to continued tobacco use, which is one of the leading preventable causes of death worldwide, causing more than 8 million deaths per year.

Nicotine Anonymous (NicA) is a twelve-step program founded in 1982 for people desiring to quit smoking and live free of nicotine. As of July 2017, there are over 700 face-to-face meetings in 32 countries worldwide with the majority of these meetings occurring in the United States, Iran, India, Canada, Brazil, the United Kingdom, Australia, Russia and in various online community and social media platforms.. NicA maintains that total abstinence from nicotine is necessary for recovery. NicA defines abstinence as “a state that begins when all use of nicotine ceases.

<span class="mw-page-title-main">Substance use disorder</span> Continual use of drugs (including alcohol) despite detrimental consequences

Substance use disorder (SUD) is the persistent use of drugs despite the substantial harm and adverse consequences to one's own self and others, as a result of their use. In perspective, the effects of the wrong use of substances that are capable of causing harm to the user or others, have been extensively described in different studies using a variety of terms such as substance use problems, problematic drugs or alcohol use, and substance use disorder. The National Institute of Mental Health (NIMH) states that "Substance use disorder (SUD) is a treatable mental disorder that affects a person's brain and behavior, leading to their inability to control their use of substances like legal or illegal drugs, alcohol, or medications. Symptoms can be moderate to severe, with addiction being the most severe form of SUD". Substance use disorders (SUD) are considered to be a serious mental illness that fluctuates with the age that symptoms first start appearing in an individual, the time during which it exists and the type of substance that is used. It is not uncommon for those who have SUD to also have other mental health disorders. Substance use disorders are characterized by an array of mental/emotional, physical, and behavioral problems such as chronic guilt; an inability to reduce or stop consuming the substance(s) despite repeated attempts; operating vehicles while intoxicated; and physiological withdrawal symptoms. Drug classes that are commonly involved in SUD include: alcohol (alcoholism); cannabis; opioids; stimulants such as nicotine, cocaine and amphetamines; benzodiazepines; barbiturates; and other substances.

<span class="mw-page-title-main">Addiction</span> Disorder resulting in compulsive behaviours

Addiction is a neuropsychological disorder characterized by a persistent and intense urge to use a drug or engage in a behaviour that produces natural reward, despite substantial harm and other negative consequences. Repetitive drug use often alters brain function in ways that perpetuate craving, and weakens self-control. This phenomenon – drugs reshaping brain function – has led to an understanding of addiction as a brain disorder with a complex variety of psychosocial as well as neurobiological factors that are implicated in addiction's development. Classic signs of addiction include compulsive engagement in rewarding stimuli, preoccupation with substances or behavior, and continued use despite negative consequences. Habits and patterns associated with addiction are typically characterized by immediate gratification, coupled with delayed deleterious effects.

<span class="mw-page-title-main">Smoking in Syria</span> Legality, popularity and history of smoking in Syria

Smoking in Syria is steadily increasing in popularity amongst the Syrian population, mainly in the forms of cigarettes or narghiles. In Syria, the General Organization of Tobacco manages the growth and exportation of tobacco products. Syrians collectively spend about $600 million per year on tobacco consumption. As of 2010, 20% of women and 60% of men smoke and 98% of the overall population is affected by passive smoking. Narghiles and cigarettes are the two main forms of tobacco consumption. Despite the assumption that smoking, specifically the narghile, is embedded in Syrian culture, this phenomenon has only recently become widespread. Health officials are currently working on smoking cessation programs and policies, to remove this idea that smoking in Syria is an essential part of the culture, to educate regarding health effects, and to prevent citizens from smoking in public places.

Linda Carter Sobell, Ph.D., ABPP, is the President's Distinguished Professor at Nova Southeastern University (NSU) in Fort Lauderdale, Florida. She is a professor of clinical psychology, addiction specialist, co-director of NSU's Guided Self-Change clinic, a Motivational Interviewing Trainer, and is board-certified in cognitive and behavioral psychology.

Guided self-change (GSC) treatment has been accepted by American Psychological Association Division 12, Society of Clinical Psychology, as an empirically supported treatment.

Jed Eugene Rose is an American academic professor, inventor and researcher in the field of nicotine and smoking cessation. Rose is presently the President and CEO of the Rose Research Center, LLC in Raleigh, North Carolina. Additionally, he is the Director of the Duke Center for Smoking Cessation at Duke University Medical Center.

<span class="mw-page-title-main">Jonathan Bricker</span>

Jonathan B. Bricker is an American clinical psychologist, academic, and scientist. He is a Full Professor in the Division of Public Health Sciences (PHS) at the Fred Hutchinson Cancer Center, an Affiliate Professor in the Department of Psychology, and a Member of the Graduate Faculty at the University of Washington. He is the founder and leader of the Health and Behavioral Innovations in Technology (HABIT) research lab at the Fred Hutch Cancer Center. Throughout his career, Bricker has led an NIH-funded clinical research team, provided clinical intervention and supervision, and given invited keynote lectures internationally on topics including behavioral interventions, tobacco cessation and substance addiction, and weight less.

References

  1. Zhu, Shu-Hong; Melcer, Ted; Sun, Jichao; Rosbrook, Bradley; Pierce, John P (May 2000). "Smoking cessation with and without assistance: A population-based analysis". American Journal of Preventive Medicine. 18 (4): 305–11. doi:10.1016/S0749-3797(00)00124-0. PMID   10788733.
  2. Zhu, Shu-Hong; Anderson, Christopher M.; Tedeschi, Gary J.; Rosbrook, Bradley (3 October 2002). "Evidence of Real-World Effectiveness of a Telephone Quitline for Smokers" (PDF). The New England Journal of Medicine. 347 (14): 1087–93. doi:10.1056/NEJMsa020660. PMID   12362011. S2CID   8364269.
  3. Helgason, AR; Tomson, T; Lund, KE; Galanti, R; Ahnve, S; Gilljam, H (September 2004). "Factors related to abstinence in a telephone helpline for smoking cessation". European Journal of Public Health. 14 (3): 306–10. doi: 10.1093/eurpub/14.3.306 . PMID   15369039.
  4. Wadland, William C.; Stoffelmayr, Bertram; Berger, Ellen; Crombach, Anna; Ives, Kathy (September 1999). "Enhancing smoking cessation rates in primary care". Journal of Family Plastic. 48 (9): 711–718. PMID   10498078 . Retrieved 23 January 2019.
  5. Tomson, T; Helgason, AR; Gilljam, H (2004). "Quitline in smoking cessation: A cost-effectiveness analysis". International Journal of Technological Assessment in Health Cate. 20 (4): 469–74. doi:10.1017/S0266462304001370. hdl: 10616/41159 . PMID   15609797. S2CID   21602691.
  6. Agency for Healthcare Research and Quality (May 2008). Treating tobacco use and dependence: 2008 update. US Department of Health and Human Services. Retrieved 23 January 2019.{{cite book}}: |website= ignored (help)
  7. Lindgvist, H; Forsberg, LG; Forsberg, L; Rosendahl, I; Enebrink, P; Halgason, AR (July 2013). "Motivational interviewing in an ordinary clinical setting: a controlled clinical trial at the Swedish National Tobacco Quitline". Addictive Behaviors. 38 (7): 2321–4. doi: 10.1016/j.addbeh.2013.03.002 . PMID   23584193.
  8. Drehmer, Jeremy E.; Hipple, Bethany; Nabi-Burza, Emara; Ossip, Deborah J.; Chang, Yuchiao; Rigotti, Nancy A.; Winickoff, Jonathan P. (24 June 2016). "Proactive enrollment of parents to tobacco quitlines in pediatric practices is associated with greater quitline use: a cross-sectional study". BMC Public Health. 16: 520. doi: 10.1186/s12889-016-3147-1 . PMC   4919852 . PMID   27342141.
  9. Ahacic, Kozma; Nederfeldt, Lena; Helgason, Asgeir R (11 July 2014). "The national alcohol helpline in Sweden: an evaluation of its first year". Substance Abuse Treatment, Prevention, and Policy. 9: 28. doi: 10.1186/1747-597X-9-28 . PMC   4100057 . PMID   25015403.